- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06171945
Mobile Weight Loss Intervention for Adolescent and Young Adult Cancer Survivors (AYAConnect)
A Pilot Randomized Trial of a Mobile Weight Loss Intervention for Adolescent and Young Adult Cancer Survivors
Study Overview
Status
Detailed Description
The purpose of this study is to conduct a 6-month pilot randomized trial to determine the feasibility and acceptability of three adapted theory-based, mobile weight loss interventions delivered via a native smartphone application among AYAs: 1) AYA Connect; 2) AYA Connect enhanced with positive psychology strategies (AYA Connect-PP); and 3) AYA Connect enhanced with positive psychology strategies plus coaching (AYA Connect-PP+).
The 3-month interventions are aimed at promoting improvements in diet quality consistent with recommendations for cancer survivors, a decrease in energy intake, an increase in energy expenditure, modest weight loss, and an increase in positive affect. The 3-month interventions will be followed by a 3-month maintenance phase (no contact). Assessments will occur at baseline, 3 (post-intervention), and 6 months (maintenance). Weight will be collected via smart scales mailed to participants. Adherence measures will include daily self-monitoring of weight (smart scale), physical activity (activity tracker), and dietary intake (food log in AYA Connect app).
Young adults (n=60), ages 18-39, diagnosed with invasive malignancy between the ages of 15-39 years, post-cancer treatment, with body mass index (BMI) of 25-50 kg/m2 will be recruited from around the United States to participate in the pilot randomized trial. Participants will be randomized into one of three conditions: 1) AYA Connect intervention; 2) AYA Connect-PP intervention; and 3) AYA Connect-PP+ intervention.
Group 1: AYA Connect Intervention: These participants will receive a smart scale, activity tracker, an individual kickoff video chat session with a health coach, and access to a mobile smartphone app that includes weekly behavioral lessons, dietary tracking log, daily weight-related behavioral goals, tailored feedback summaries, and in-app health-related messages.
Group 2: AYA Connect-PP Intervention: In addition to the intervention components Group 1 will receive, these participants will also receive lessons about positive psychology (PP) strategies, weekly goals for PP exercises, and in-app health-related messages that include reminders to practice PP exercises.
Group 3: AYA Connect-PP+ Intervention: In addition to the intervention components Group 2 will receive, these participants also will receive weekly individual video chat sessions with a health coach.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Molly Diamond, MPH
- Phone Number: (919) 966-5852
- Email: mdiamond@unc.edu
Study Locations
-
-
North Carolina
-
Chapel Hill, North Carolina, United States, 27599
- Recruiting
- Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill
-
Contact:
- Molly Diamond, MPH
- Phone Number: 919-966-5852
- Email: mdiamond@unc.edu
-
Contact:
- E., MPH
-
Principal Investigator:
- Carmina G. Valle, PhD, MPH
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
In order to participate in this study a subject must meet all of the eligibility criteria outlined below.
Inclusion Criteria:
- Currently age 18-39
- Diagnosed with first invasive cancer between the ages of 15-39 years old
- Within 10 years of diagnosis with no evidence of progressive disease or second primary cancers
- Completed active cancer-directed therapy (cytotoxic chemotherapy, radiation therapy, and/or definitive surgical intervention) at least six months prior to enrollment, except maybe receiving "maintenance" therapy to prevent recurrences
- Body Mass Index (BMI) of 25-50 kg/m2
Exclusion Criteria:
- Type 1 diabetes or currently receiving medical treatment for Type 2 diabetes
- Report a history of heart attack or stroke within the previous 6 months
- Health problems that preclude the ability to walk for physical activity
- Lost 5% or more of body weight (and kept it off) in the last 3 months
- Past diagnosis of or receiving treatment for a clinically diagnosed eating disorder (anorexia nervosa or bulimia nervosa) or any compensatory behaviors within the previous 3 months
- Currently pregnant, pregnant within the past 6 months, or planning to become pregnant within the next 6 months
- Untreated thyroid disease or any changes (type or dose) in thyroid medication in the last 6 months
- Hospitalization for depression or other psychiatric disorder within the past 12 months
- History of psychotic disorder or bipolar disorder
- Currently participating in a weight loss, nutrition, or physical activity study or program or other study that would interfere with this study
- Currently using prescription medications with known effects on appetite or weight.
- Previous surgical procedure for weight loss or planned weight loss surgery in the next 6 months
- Inability to speak and read English
- Do not have an iPhone with active data and text messaging plan
- No Internet access
- Not willing to be randomized to either intervention arm
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: AYA Connect
Adolescent and young adult cancer survivors receive AYA Connect intervention.
|
Participants will receive a smart scale, activity tracker, an individual kickoff videochat session with a health coach, and access to a mobile smartphone app that includes weekly behavioral lessons, dietary tracking log, daily weight-related behavioral goals, tailored feedback summaries, and in-app health-related messages.
|
Experimental: AYA Connect-PP
Adolescent and young adult cancer survivors receive AYA Connect-PP intervention.
|
Participants will receive a smart scale, activity tracker, an individual kickoff videochat session with a health coach, and access to a mobile smartphone app that includes weekly behavioral lessons, dietary tracking log, daily weight-related behavioral goals, tailored feedback summaries, and in-app health-related messages.
Participants will receive lessons about positive psychology (PP) strategies, weekly goals for PP exercises, and in-app health-related messages that include reminders to practice PP exercises.
|
Experimental: AYA Connect-PP+
Adolescent and young adult cancer survivors receive AYA Connect-PP+ intervention.
|
Participants will receive a smart scale, activity tracker, an individual kickoff videochat session with a health coach, and access to a mobile smartphone app that includes weekly behavioral lessons, dietary tracking log, daily weight-related behavioral goals, tailored feedback summaries, and in-app health-related messages.
Participants will receive lessons about positive psychology (PP) strategies, weekly goals for PP exercises, and in-app health-related messages that include reminders to practice PP exercises.
Participants will receive weekly individual videochat sessions with a health coach.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Feasibility of interventions as measured by accrual rate
Time Frame: at 3 months
|
Feasibility of interventions as measured by accrual rate will be calculated as the number of adolescent and young adult cancer (AYA) survivors who agreed to participate divided by the number of months of recruitment
|
at 3 months
|
Feasibility of interventions as measured by participation rate
Time Frame: at 3 months
|
Feasibility of interventions as measured by participation rate will be calculated as the number of participants who agreed to participate divided by the number of eligible AYA survivors.
|
at 3 months
|
Feasibility of interventions as measured by retention rate
Time Frame: At 3 months
|
Feasibility of interventions as measured by retention rate will be calculated as the number of AYA survivor participants who completed 3-month measures divided by the number who participated.
|
At 3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Retention rate at 6 months
Time Frame: At 6 months
|
Retention rate at 6 months, calculated by the number of participants who completed all study measures at the 6-month time point divided by the number who participated.
|
At 6 months
|
Acceptability of Young Adult Cancers (AYAs) Connect
Time Frame: At 3 and 6 month
|
Acceptability of the interventions will be measured by ratings of program acceptability and satisfaction.
Participants will provide ratings on the helpfulness and difficulty of the program's behavioral goals (e.g., diet and physical activity goals) using an 8-point scale (1 = Not satisfied/Very difficult to 8 = Very satisfied/very easy).
Additional questions will ask participants about the helpfulness of intervention features (e.g., lessons, feedback messages) for reaching their weight goals (1 = Not at all helpful to 4 = Extremely helpful).
Higher scores indicate greater acceptability.
|
At 3 and 6 month
|
Adherence to dietary tracking
Time Frame: Up to 6 month
|
Number of days red foods (high-calorie, high-fat foods) are tracked, as measured by the food log data in the AYA Connect app.
Participants will be asked to log their red foods in the app daily.
|
Up to 6 month
|
Adherence to physical activity monitoring
Time Frame: Up to 6 month
|
Number of days physical activity is tracked, as measured by activity tracker
|
Up to 6 month
|
Adherence to self-weighing
Time Frame: Up to 6 month
|
Number of days weighed, as measured by smart scale
|
Up to 6 month
|
Change in weight
Time Frame: Up to 6 month
|
Change in weight, as measured by smart scale, from baseline to 3 and 6 months.
|
Up to 6 month
|
Change in energy intake
Time Frame: from the baseline to 3 and 6 month
|
Change in energy intake (kcal), measured using the NCI Automated Self-Administered 24-hour Recall (ASA-24).
The ASA-24 will be administered on one weekend day and one week day per assessment period to estimate energy intake.
|
from the baseline to 3 and 6 month
|
Change in saturated fat intake
Time Frame: from the baseline to 3 and 6 month
|
Change in saturated fat intake (% kcal), measured using the NCI Automated Self-Administered 24-hour Recall (ASA-24 The ASA-24 will be administered on one weekend day and one week day per assessment period to estimate saturated fat intake.
|
from the baseline to 3 and 6 month
|
Change in fruit and vegetable consumption
Time Frame: from the baseline to 3 and 6 month
|
Change in fruit and vegetable consumption (cups), measured using the NCI Automated Self-Administered 24-hour Recall (ASA-24).
The ASA-24 will be administered on one weekend day and one week day per assessment period to estimate average fruit and vegetable consumption.
|
from the baseline to 3 and 6 month
|
Change in fiber consumption
Time Frame: from the baseline to 3 and 6 month
|
Change in fiber consumption (g), measured using the NCI Automated Self-Administered 24-hour Recall (ASA-24).
The ASA-24 will be administered on one weekend day and one week day per assessment period to estimate fiber consumption.
|
from the baseline to 3 and 6 month
|
Change in Healthy Eating Index score
Time Frame: from the baseline to 3 and 6 month
|
Change in Healthy Eating Index (HEI) score, measured using the HEI and the NCI Automated Self-Administered 24-hour Recall (ASA-24).
The ASA-24 will be administered on one weekend day and one week day per assessment period to estimate HEI.
HEI scores range from 0 to 100, with higher scores indicating greater adherence to the Dietary Guidelines for Americans.
|
from the baseline to 3 and 6 month
|
Change in weekly minutes of moderate-to-vigorous activity
Time Frame: From baseline to 3 and 6 months
|
Changes in weekly minutes of moderate-to-vigorous activity, computed from the participant's activity tracker data and averaged over a minimum of 4 out of a 7-day period.
Participants will be instructed to wear the activity tracker at all times.
|
From baseline to 3 and 6 months
|
Change in steps per day
Time Frame: From baseline to 3 and 6 months
|
Changes in daily steps, were computed from the participant's activity tracker data and averaged over a minimum of 4 out of a 7-day period.
Participants will be instructed to wear the activity tracker at all times.
|
From baseline to 3 and 6 months
|
Change in self-reported physical activity
Time Frame: From baseline to 3 and 6 months
|
Change in self-reported physical activity, measured using the Paffenbarger Activity Scale (PAQ).
The PAQ provides an estimate of minutes per week of moderate-to-vigorous intensity, and calories/week of light (5 kcal/min), medium (7.5 kcal/min), and high (10 kcal/min) intensity activities.
PAQ changes have been predictive of weight change.
|
From baseline to 3 and 6 months
|
Change in frailty index
Time Frame: From baseline to 3 and 6 months
|
Change in frailty index, measured using the FRAIL Questionnaire.
The FRAIL Questionnaire assesses: 1) self-reported fatigue (1 item from Patient-Reported Outcomes Measurement Information System (PROMIS) Global Health), 2) weight loss, 3) comorbidities (11 items from UNC Health Registry Comorbidity Assessment), 4) difficulty with ambulation (1 item from PROMIS Global Health), and 5) ability to overcome resistance (1 item from Medical Outcomes Study 36-Item Short Form).
Positive responses for these components are summed to create the FRAIL index (range 0-5).
A value > 3 is considered frail, and a value of 2 is considered prefrail.
|
From baseline to 3 and 6 months
|
Change in health-related quality of life
Time Frame: From baseline to 3 and 6 months
|
Change in health-related quality of life, measured using the Medical Outcomes Study 36-Item Short Form (SF-36) survey.
This survey includes 36 items with eight subscales (physical functioning, role limitations due to physical problems, social functioning, bodily pain, general mental health, role limitations due to emotional problems, vitality, and general health perceptions).
Responses are coded on a scale of 0 to 100, where 0 is the worst possible health and 100 is the most favorable health score.
The coded responses will be summed to yield a Physical Component Summary (PCS) score and a Mental Component Summary (MCS) score.
|
From baseline to 3 and 6 months
|
Change in depressive symptoms
Time Frame: From baseline to 3 and 6 months
|
Change in depressive symptoms, measured by the Center for Epidemiological Studies Depression Scale (CES-D).
The CES-D is a self-report depression scale including 20 items that relate to depressive feelings and behaviors during the past week.
Response options range from 0 (rarely or none of the time) to 3 (most or almost All the Time).
Scores range from 0 to 60, with high scores indicating greater depressive symptoms.
|
From baseline to 3 and 6 months
|
Change in anxiety symptoms
Time Frame: From baseline to 3 and 6 months
|
Change in anxiety symptoms, as measured using the Generalized Anxiety Disorder 7-item scale (GAD-7).
Possible scores range from 0 to 21, with higher scores reflecting greater symptom severity; cut-points of 5, 10, and 15 correspond to mild, moderate, and severe levels of anxiety.
|
From baseline to 3 and 6 months
|
Change in perceived stress
Time Frame: From baseline to 3 and 6 months
|
Change in perceived stress, measured by the 10-item Perceived Stress Scale (PSS-10).
PSS-10 measures overall perceived stress during the past month.
Factor analysis supports a two-factor correlated model with perceived self-efficacy and perceived helplessness subscales.
|
From baseline to 3 and 6 months
|
Change in positive and negative affect
Time Frame: From baseline to 3 and 6 months
|
Change in positive and negative affect, measured using the Positive and Negative Affect Schedule (PANAS).
PANAS is a 20-item scale divided into two subscales to measure positive and negative affect.
Each item is rated on a five-point Likert scale from 1 (very slightly or not at all) to 5 (extremely) and are summed to yield scores for each subscale.
|
From baseline to 3 and 6 months
|
Collaborators and Investigators
Investigators
- Principal Investigator: Carmina Valle, PhD, UNC Lineberger Comprehensive Cancer Center
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- LCCC2133
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Central Hospital, Nancy, FranceNot yet recruiting
-
University of MinnesotaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Active, not recruitingAdolescent ObesityUnited States
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsActive, not recruitingOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Fundació Sant Joan de DéuRecruitingObesity, Childhood | Obesity, AdolescentSpain
Clinical Trials on AYA Connect intervention
-
Duke UniversityNot yet recruitingSarcoma | Lymphoma | Cancer | Breast Cancer | Colorectal Cancer | Testicular Cancer
-
University of South CarolinaNational Institute of Nursing Research (NINR)RecruitingConnect Through PLAY: A Staff-based Physical Activity Intervention for Middle School Youth (Connect)Physical Activity | Obesity PreventionUnited States
-
Wake Forest University Health SciencesLung Cancer Research FoundationCompleted
-
US Department of Veterans AffairsDuke UniversityCompletedAccidental FallsUnited States
-
University of South CarolinaEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedPhysical Activity | Obesity Prevention
-
Abramson Cancer Center at Penn MedicineActive, not recruitingAdolescent and Young Adult (AYA) Cancer SurvivorsUnited States
-
Columbia UniversityNational Institute on Drug Abuse (NIDA)Active, not recruitingHIV | Sexually Transmitted InfectionsUnited States
-
Duke UniversityRecruitingCardiovascular Diseases | Pain | Cancer | Fatigue | Weight Management | Distress, Emotional | Physical InactivityUnited States
-
Massachusetts General HospitalNational Cancer Institute (NCI)Active, not recruitingCancerUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)Completed